Darren Ming-Chun Poon, MBChB, FRCR, FHKCR. FHKAM (Radiology)

Dr Darren Ming-Chun Poon is the Honorary Clinical Associate Professor at the Chinese University of Hong Kong and the Honorary Consultant in Clinical Oncology at both the Hong Kong Sanatorium & Hospital and Prince of Wales Hospital, Hong Kong.

Dr Poon has several specialist areas of expertise, which include genitourinary (GU) cancer, neuro-oncology, hepato-pancreatic cancer, and head and neck cancer. His research interests include novel therapies for GU cancers, image-guided radiotherapy and stereotactic body radiotherapy (SBRT) for prostate, central nervous system tumor, pancreatic and liver cancer. Dr Poon pioneered the use of SBRT in the treatment of prostate cancer in Hong Kong and completed the first-in-Asia randomized study for prostate SBRT. He has published more than 50 original papers, scientific reviews, and abstracts in peer-reviewed journals and has co-authored the 10th edition of Fast Facts: Prostate Cancer. He is one of the expert panel members in the Advanced Prostate Cancer Consensus Conference (APCCC) from 2019 onwards, and the Asia Pacific Advanced Prostate Cancer Consensus Conference (APAC-APCCC) from 2020 onwards. Dr Poon has been an invited speaker at local and regional, and international conferences and is currently involved in several clinical trials investigating new therapies for urothelial, bladder, renal and prostate cancers.

In addition to his clinical and academic duties, Dr Poon has been Vice-President of several professional societies, including the Hong Kong Society of Uro-Oncology, Hong Kong Nasopharyngeal Carcinoma Study Group and the Hong Kong SBRT study group. In addition, he is a Council Member of the Hong Kong Prostate Foundation and Vice-Chairman of the Hand in Hand Cancer Foundation.

Editorial Board (Urologic Oncology)
Terms of Appointment: August 2022 - July 2024;  August 2024 - July 2026